Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Huimei Technology

Explore full profile

Huimei Technology is an artificial intelligence (AI)-powered medical solutions provider

Haidian, ChinaFounded 2015Health Tech & Medtech
Valuation $500M–1B Last recorded · 2025
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Huimei Technology and the history behind them.

About Huimei Technology

Founded in 2015, Huimei Technology, also known as Huimei Healthcare, operates as a medical artificial intelligence solutions provider. The company was established as a division of Huimei Healthcare Management Services, which was a 2015 joint venture between Hillhouse Capital and the U.S.-based Mayo Clinic. The founder and CEO is Zhang Qi, who previously served as the head of the algorithm team for Alibaba Group's Tmall platform. Zhang has stated that his motivation was to address the lag in medical quality management and patient safety by leveraging technology to overcome the shortcomings of traditional "experience medicine".

Huimei Technology's business is centered on developing AI-powered solutions to enhance clinical quality for healthcare providers. The company serves the hospital market, with its AI product portfolio covering over 1,200 graded hospitals in China, more than 70% of which are tertiary hospitals. Its business model involves providing these institutions with advanced software systems designed to improve diagnostics, data management, and overall medical service quality. The core of their offering is an AI-based medical quality control system that uses technologies like natural language processing and deep learning to analyze clinical big data.

The company's flagship product is Dr. Mayson, a clinical decision support system (CDSS). This system assists doctors by providing real-time diagnostic suggestions, medication guidance, and risk warnings directly within the clinical workflow. Dr. Mayson is designed to automate and improve Plan-Do-Check-Act (PDCA) cycles in healthcare management, covering pre-diagnosis to post-diagnosis stages. Other key products include a disease process quality management system, a medical knowledge base, and a smart VTE (venous thromboembolism) prevention and control system. For instance, the VTE system reportedly increased successful diagnoses by 85% at one Beijing hospital shortly after launch. To ensure clinical relevance, the company employs a team of over 30 full-time doctors to help design its algorithms.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Haidian, China
Employees
24
Open positions
None listed
Dealroom signal
70.9/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Medical Imaging, Core AI, Tech for Hospitals and Clinics, Clinical Decision Support, Hard Tech, AI Applications, DT and LS
Technology
Artificial Intelligence, Deep Tech, Machine Learning
Client focus
b2b
Investment activity
4 companies, latest Jun 2024
Capital deployed
$72M
Preferred round
SERIES B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Aug 2025 $28M $550M Qiming Venture Partners · Eastern Bell Capital · Shanghai Science and Technology Innovation Center ↗
SERIES DOther financing Jan 2024 $9.9M $550M NRL Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Huimei Technology website traffic

Latest recorded traffic for Huimei Technology is 720 monthly website visits, up 500% over the last three months. Huimei Technology's team grew 0% over the past year.

Latest monthly visits720 3-month web change+500% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

  • Qiming Venture Partners
  • WuXi AppTec
  • Runzhang Venture Capital
  • Suzhou Yihe
  • Eastern Bell Capital
  • NRL Capital
  • Shanghai Science and Technology Innovation Center
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇹🇭 Thailand50%
🇨🇳 China33.3%
🇺🇸 United States16.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Huimei Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Huimei Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.